Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Gross Margin (2016 - 2026)

Biomerica's Gross Margin history spans 17 years, with the latest figure at 4.46% for Q1 2026.

  • Quarterly results put Gross Margin at 4.46% for Q1 2026, down 616.0% from a year ago — trailing twelve months through Feb 2026 was 4.32% (down 915.0% YoY), and the annual figure for FY2025 was 9.38%, down 191.0%.
  • Gross Margin for Q1 2026 was 4.46% at Biomerica, down from 4.21% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 30.72% in Q3 2025 to a low of 32.58% in Q2 2025.
  • The 5-year median for Gross Margin is 10.8% (2023), against an average of 8.33%.
  • The sharpest move saw Gross Margin skyrocketed 2741bps in 2023, then tumbled -3437bps in 2025.
  • Year by year, Gross Margin stood at 23.75% in 2022, then fell by -13bps to 20.74% in 2023, then grew by 29bps to 26.71% in 2024, then plummeted by -84bps to 4.21% in 2025, then tumbled by -206bps to 4.46% in 2026.
  • According to Business Quant data, Gross Margin over the past three periods came in at 4.46%, 4.21%, and 30.72% for Q1 2026, Q4 2025, and Q3 2025 respectively.